Gemifloxacinisafluoroquinoloneantibioticthatdisplaysantibacterialactivityagainstbothgrampositiveandgramnegativebacteria.GemifloxaciniscommonlyusedasashortcourseoftreatmentforacuteexacerbationsofchronicbronchitisandCOPD.ThiscompoundisalsoaneffectivetreatmentforStreptococcuspneumoniae-inducedcommunity-acquiredpneumonia.
| CasNo. | 210353-53-0 |
|---|---|
| Purity | ≥98% |
| Formula | C18H20FN5O4•CH3SO3H |
| FormulaWt. | 485.49 |
| IUPACName | 7-[(4Z)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylicacid;methanesulfonicacid |
| Appearance | Offwhitetoyellowishpowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | G1849MSDSPDF |
|---|---|
| InfoSheet | G1849InfoSheetPDF |
AnzuetoA,MiravitllesM.Short-coursefluoroquinolonetherapyinexacerbationsofchronicbronchitisandCOPD.RespirMed.2010Oct;104(10):1396-403.PMID:20580215.
LodeHM,Schmidt-IonasM,StahlmannR.Gemifloxacinforcommunity-acquiredpneumonia.ExpertOpinInvestigDrugs.2008May;17(5):779-86.PMID:18447602.
BhavnaniSM,AndesDR.Gemifloxacinforthetreatmentofrespiratorytractinfections:invitrosusceptibility,pharmacokineticsandpharmacodynamics,clinicalefficacy,andsafety.Pharmacotherapy.2005May;25(5):717-40.PMID:15899734.
